Rothschild Investment LLC’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5K | Sell |
102
-72
| -41% | -$10.9K | ﹤0.01% | 1086 |
|
|
2025
Q1 | $26.2K | Buy |
174
+144
| +480% | +$21.7K | ﹤0.01% | 927 |
|
|
2024
Q4 | $5.54K | Buy |
30
+14
| +88% | +$2.58K | ﹤0.01% | 1310 |
|
|
2024
Q3 | $3.15K | Sell |
16
-1
| -6% | -$197 | ﹤0.01% | 1481 |
|
|
2024
Q2 | $3.51K | Buy |
17
+6
| +55% | +$1.24K | ﹤0.01% | 1260 |
|
|
2024
Q1 | $2.98K | Buy |
11
+2
| +22% | +$542 | ﹤0.01% | 1181 |
|
|
2023
Q4 | $2.13K | Buy |
+9
| New | +$2.13K | ﹤0.01% | 1140 |
|
|
2020
Q4 | – | Sell |
-1,794
| Closed | -$407K | – | 459 |
|
|
2020
Q3 | $407K | Buy |
1,794
+464
| +35% | +$105K | 0.04% | 292 |
|
|
2020
Q2 | $232K | Sell |
1,330
-475
| -26% | -$82.9K | 0.03% | 358 |
|
|
2020
Q1 | $228K | Buy |
1,805
+126
| +8% | +$15.9K | 0.03% | 351 |
|
|
2019
Q4 | $256K | Buy |
+1,679
| New | +$256K | 0.03% | 386 |
|